Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

1.

Circadian variation of topoisomerase II-alpha in human rectal crypt epithelium: implications for reduction of toxicity of chemotherapy.

Clayton F, Tessnow KA, Fang JC, Holden JA, Moore JG.

Mod Pathol. 2002 Nov;15(11):1191-6.

PMID:
12429798
[PubMed - indexed for MEDLINE]
Free Article
2.

Immunohistochemical study of DNA topoisomerase I, DNA topoisomerase II alpha, p53, and Ki-67 in oral preneoplastic lesions and oral squamous cell carcinomas.

Hafian H, Venteo L, Sukhanova A, Nabiev I, Lefevre B, Pluot M.

Hum Pathol. 2004 Jun;35(6):745-51.

PMID:
15188142
[PubMed - indexed for MEDLINE]
3.

Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression.

Braybrooke JP, Levitt NC, Joel S, Davis T, Madhusudan S, Turley H, Wilner S, Harris AL, Talbot DC.

Clin Cancer Res. 2003 Oct 15;9(13):4682-8.

PMID:
14581337
[PubMed - indexed for MEDLINE]
Free Article
4.

Topoisomerase II-alpha expression in different cell cycle phases in fresh human breast carcinomas.

Villman K, Ståhl E, Liljegren G, Tidefelt U, Karlsson MG.

Mod Pathol. 2002 May;15(5):486-91.

PMID:
12011253
[PubMed - indexed for MEDLINE]
Free Article
5.

Human topoisomerase II-alpha is highly expressed in sinonasal-inverted papilloma, but not in inflammatory polyp.

Hadar T, Shvero J, Yaniv E, Shvili I, Leabu M, Koren R.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1551-8. doi: 10.1111/j.1582-4934.2008.00381.x. Epub 2008 Jun 9.

PMID:
18544048
[PubMed - indexed for MEDLINE]
6.

Human DNA topoisomerase II-alpha expression in laparoscopically treated renal cell carcinoma.

Dekel Y, Frede T, Kugel V, Neumann G, Rassweiler J, Koren R.

Oncol Rep. 2005 Jul;14(1):271-4.

PMID:
15944800
[PubMed - indexed for MEDLINE]
7.

Circadian rhythm of cellular proliferation in the human rectal mucosa.

Buchi KN, Moore JG, Hrushesky WJ, Sothern RB, Rubin NH.

Gastroenterology. 1991 Aug;101(2):410-5.

PMID:
2065918
[PubMed - indexed for MEDLINE]
8.

Topoisomerase II alpha expression and cytotoxicity of anthracyclines in human neoplastic cells.

Gruber BM, Anuszewska EL, Roman I, Goździk A, Priebe W, Fokt I.

Acta Pol Pharm. 2006 Jan-Feb;63(1):15-8. Erratum in: Acta Pol Pharm. 2006 Mar-Apr;63(2):155.

PMID:
17515324
[PubMed - indexed for MEDLINE]
Free Article
9.

Characterization of human NSCLC cell line with innate etoposide-resistance mediated by cytoplasmic localization of topoisomerase II alpha.

de Lucio B, Manuel V, Barrera-Rodríguez R.

Cancer Sci. 2005 Nov;96(11):774-83.

PMID:
16271071
[PubMed - indexed for MEDLINE]
10.

N-acetyl-p-benzoquinone imine, the toxic metabolite of acetaminophen, is a topoisomerase II poison.

Bender RP, Lindsey RH Jr, Burden DA, Osheroff N.

Biochemistry. 2004 Mar 30;43(12):3731-9.

PMID:
15035644
[PubMed - indexed for MEDLINE]
11.

Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior.

Vidal S, Kovacs K, Horvath E, Rotondo F, Kuroki T, Lloyd RV, Scheithauer BW.

Mod Pathol. 2002 Nov;15(11):1205-12.

PMID:
12429800
[PubMed - indexed for MEDLINE]
Free Article
12.

Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.

Shvero J, Koren R, Shvili I, Yaniv E, Sadov R, Hadar T.

Am J Clin Pathol. 2008 Dec;130(6):934-9. doi: 10.1309/AJCPROG61USKCBEI.

PMID:
19019771
[PubMed - indexed for MEDLINE]
Free Article
13.

DNA topoisomerase I and IIalpha expression in penile carcinomas: assessing potential tumour chemosensitivity.

Berney DM, Stankiewicz E, Adlan AM, Kudahetti S, Biedrzycki OJ, Hadway P, Watkin N, Corbishley C.

BJU Int. 2008 Sep;102(8):1040-4. doi: 10.1111/j.1464-410X.2008.07698.x. Epub 2008 May 16.

PMID:
18489530
[PubMed - indexed for MEDLINE]
14.

A dual mechanism of action of the anticancer agent F 11782 on human topoisomerase II alpha.

Jensen LH, Renodon-Cornière A, Nitiss KC, Hill BT, Nitiss JL, Jensen PB, Sehested M.

Biochem Pharmacol. 2003 Aug 15;66(4):623-31.

PMID:
12906927
[PubMed - indexed for MEDLINE]
15.

DNA topoisomerase II-alpha as a proliferation marker in human gliomas: correlation with PCNA expression and patient survival.

Zhao H, Yu H, Liu Y, Wang Y, Cai W.

Clin Neuropathol. 2008 Mar-Apr;27(2):83-90.

PMID:
18402387
[PubMed - indexed for MEDLINE]
16.

Expression of cyclooxygenase-2 and DNA topoisomerase II alpha in precancerous and cancerous lesions of the oral mucosa.

Segawa E, Sakurai K, Kishimoto H, Takaoka K, Noguchi K, Hashitani S, Hirota S, Urade M.

Oral Oncol. 2008 Jul;44(7):664-71. Epub 2007 Nov 9.

PMID:
17996482
[PubMed - indexed for MEDLINE]
17.

CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors.

Yang DT, Holden JA, Florell SR.

J Cutan Pathol. 2004 Mar;31(3):254-61.

PMID:
14984578
[PubMed - indexed for MEDLINE]
18.

Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapy.

Kuropkat C, Rudolph P, Parwaresch R, Werner JA.

Anticancer Res. 2003 Sep-Oct;23(5A):3965-70.

PMID:
14666704
[PubMed - indexed for MEDLINE]
19.

Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.

Bildrici K, Tel N, Ozalp SS, Yalcin OT, Yilmaz V.

Eur J Gynaecol Oncol. 2002;23(6):540-4.

PMID:
12556100
[PubMed - indexed for MEDLINE]
20.

Effects of benzene metabolites on DNA cleavage mediated by human topoisomerase II alpha: 1,4-hydroquinone is a topoisomerase II poison.

Lindsey RH Jr, Bender RP, Osheroff N.

Chem Res Toxicol. 2005 Apr;18(4):761-70.

PMID:
15833037
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk